Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Orla C Sheehan

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Stroke|July 3, 2010
Stroke subtype classification to mechanism-specific and undetermined categories by TOAST, A-S-C-O, and causative classification system: direct comparison in the North Dublin population stroke studyMichael Marnane, Caroline A Duggan, Orla C Sheehan, et al.
Journal of General Internal Medicine|July 31, 2020
Designing a Primary Care-Based Deprescribing Intervention for Patients with Dementia and Multiple Chronic Conditions: a Qualitative StudyAriel R Green, Cynthia M Boyd, Kathy S Gleason, et al.
Annals of Neurology|March 31, 2012
Carotid plaque inflammation on 18F-fluorodeoxyglucose positron emission tomography predicts early stroke recurrenceMichael Marnane, Aine Merwick, Orla C Sheehan, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 12, 2020
Informing Patient-Centered Care Through Stakeholder Engagement and Highly Stratified Quantitative Benefit-Harm AssessmentsHélène E Aschmann, Cynthia M Boyd, Craig W Robbins, et al.
Journal of the American Geriatrics Society|December 12, 2022
Intervention design in cognitively impaired populations-Lessons learned from the OPTIMIZE deprescribing pragmatic trialOrla C Sheehan, Kathy S Gleason, Elizabeth A Bayliss, et al.
Patient Education and Counseling|October 22, 2025
Integrating patient education on deprescribing into care delivery: Learnings from the Optimize pragmatic trialElizabeth A Bayliss, Kathy S Gleason, Orla C Sheehan, et al.
Pharmacoepidemiology and Drug Safety|April 8, 2025
Discontinuation Categories Underlying Gaps in Dispensing for Six Medication GroupsElizabeth A Bayliss, Glenn K Goodrich, Jennifer C Barrow, et al.
BMJ Open|September 1, 2019
Balance of benefits and harms of different blood pressure targets in people with multiple chronic conditions: a quantitative benefit-harm assessmentHélène E Aschmann, Cynthia M Boyd, Craig W Robbins, et al.
JAMA Internal Medicine|March 28, 2022
Deprescribing Education vs Usual Care for Patients With Cognitive Impairment and Primary Care Clinicians: The OPTIMIZE Pragmatic Cluster Randomized TrialElizabeth A Bayliss, Susan M Shetterly, Melanie L Drace, et al.
Drugs & Aging|November 20, 2023
Evaluating the Safety of an Educational Deprescribing Intervention: Lessons from the Optimize TrialCynthia M Boyd, Susan M Shetterly, John D Powers, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Stroke|July 3, 2010
Stroke subtype classification to mechanism-specific and undetermined categories by TOAST, A-S-C-O, and causative classification system: direct comparison in the North Dublin population stroke studyMichael Marnane, Caroline A Duggan, Orla C Sheehan, et al.
Journal of General Internal Medicine|July 31, 2020
Designing a Primary Care-Based Deprescribing Intervention for Patients with Dementia and Multiple Chronic Conditions: a Qualitative StudyAriel R Green, Cynthia M Boyd, Kathy S Gleason, et al.
Annals of Neurology|March 31, 2012
Carotid plaque inflammation on 18F-fluorodeoxyglucose positron emission tomography predicts early stroke recurrenceMichael Marnane, Aine Merwick, Orla C Sheehan, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 12, 2020
Informing Patient-Centered Care Through Stakeholder Engagement and Highly Stratified Quantitative Benefit-Harm AssessmentsHélène E Aschmann, Cynthia M Boyd, Craig W Robbins, et al.
Journal of the American Geriatrics Society|December 12, 2022
Intervention design in cognitively impaired populations-Lessons learned from the OPTIMIZE deprescribing pragmatic trialOrla C Sheehan, Kathy S Gleason, Elizabeth A Bayliss, et al.
Patient Education and Counseling|October 22, 2025
Integrating patient education on deprescribing into care delivery: Learnings from the Optimize pragmatic trialElizabeth A Bayliss, Kathy S Gleason, Orla C Sheehan, et al.
Pharmacoepidemiology and Drug Safety|April 8, 2025
Discontinuation Categories Underlying Gaps in Dispensing for Six Medication GroupsElizabeth A Bayliss, Glenn K Goodrich, Jennifer C Barrow, et al.
BMJ Open|September 1, 2019
Balance of benefits and harms of different blood pressure targets in people with multiple chronic conditions: a quantitative benefit-harm assessmentHélène E Aschmann, Cynthia M Boyd, Craig W Robbins, et al.
JAMA Internal Medicine|March 28, 2022
Deprescribing Education vs Usual Care for Patients With Cognitive Impairment and Primary Care Clinicians: The OPTIMIZE Pragmatic Cluster Randomized TrialElizabeth A Bayliss, Susan M Shetterly, Melanie L Drace, et al.
Drugs & Aging|November 20, 2023
Evaluating the Safety of an Educational Deprescribing Intervention: Lessons from the Optimize TrialCynthia M Boyd, Susan M Shetterly, John D Powers, et al.
Pageof 8